Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Neutral on Bed Bath & Beyond, Lowers Price Target to $7

Baird analyst Justin Kleber maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Neutral and lowers the price target from $14 to $7.

byBenzinga Newsdesk

June 27, 2022

1 minute read

Baird analyst Justin Kleber maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Neutral and lowers the price target from $14 to $7.

BMO Capital Maintains Outperform on Replimune Group, Raises Price Target to $70

By Benzinga Newsdesk

Today, 6:31 AM

BMO Capital analyst Evan David Seigerman maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $40 to $70.

REPL

Amazon Participates in $40M Financing Round in Indian Fintech Startup Smallcase Technologies

By Charles Gross

Today, 6:31 AM

-Bloomberg https://www.bloomberg.com/news/articles/2021-08-18/amazon-enters-indian-wealth-management-with-bet-on-smallcase

AMZN

ID Parts Files For Resale Of Up To 2.55M Shares Of Class A Common Stock

By Benzinga Newsdesk

Today, 6:31 AM

-SEC Filing

Bill Pulte Issues Statement On Termination Of PulteGroup COO Brandon Jones

By Michael Horton

Today, 6:31 AM

The Pulte Family, the founding family of Fortune 500 PulteGroup Inc, issued the following statement following the termination of Brandon Jones, recently named Chief Operating Officer by CEO Ryan Marshall: "Today,

PHM

Baird Maintains Neutral on Bed Bath & Beyond, Lowers Price Target to $7

Related Posts

BMO Capital Maintains Outperform on Replimune Group, Raises Price Target to $70

Amazon Participates in $40M Financing Round in Indian Fintech Startup Smallcase Technologies

ID Parts Files For Resale Of Up To 2.55M Shares Of Class A Common Stock

Bill Pulte Issues Statement On Termination Of PulteGroup COO Brandon Jones